Massachusetts Medicaid Adds Prior Authorization For Elidel, Protopic
This article was originally published in The Pink Sheet Daily
Executive Summary
State’s decision to require prior authorization for Novartis’ Elidel and Astellas’ Protopic comes several months after FDA requested that labeling for the topical eczema agents include a “black box” warning for potential cancer risk. MassHealth removes prior authorization requirement for Berlex’ estrogen patch Menostar.